'Proportional hazard model' presentation slideshows

A Framework for Track Geometry Defect Risk Prediction and Repair Optimization

A Framework for Track Geometry Defect Risk Prediction and Repair Optimization. Qing He (SUNY Buffalo), Hongfei Li, Debarun Bhattacharjya , Dhaivat Parikh, and Arun Hampapur IBM T J Watson Research Center INFORMS Annual Meeting, Phoenix, AZ October 15, 2012. Outline.

385 views • 23 slides

311 views • 21 slides

Prediction of CHD using risk factor categories

Prediction of CHD using risk factor categories. Circulation . 1998; 97: 1837-47. Introduction & objective. CHD is the leading cause of morbidity and mortality in Western countries. Risk factors have been determined.

367 views • 20 slides

The CAMELIA trial CAM bodian E arly vs. L ate I ntroduction of A ntiretrovirals

ANRS 1295/12160 - CIPRA KH001/10425 trial. The CAMELIA trial CAM bodian E arly vs. L ate I ntroduction of A ntiretrovirals. F.X. Blanc , T. Sok, D. Laureillard, L. Borand, C. Rekacewicz, E. Nerrienet, Y.Madec, O. Marcy, S. Chan, N. Prak, C. Kim, K.K. Lak, C. Hak, B. Dim,

277 views • 17 slides

Systemic chemotherapy in the setting of unresectable appendiceal epithelial neoplasms

Systemic chemotherapy in the setting of unresectable appendiceal epithelial neoplasms. Eng C 1 , Blackham AU 2 , Overman M 1 , Fournier K 3 , Royal R 3 , Phillips JK 1 , Gajula P 1 , Levine EA 2 , Wolff RA 1 , Mansfield P 3

293 views • 15 slides

A Distant recurrence - tamoxifen

A Distant recurrence - tamoxifen. *4/WT. 20%. WT/WT. 15%. * 4/* 4. Recurrence (%). 10%. 5%. 0%. 0. 2. 4. 6. 8. 10. Follow-up time [years]. No. of patients at risk. WT/WT. 402. 379. 353. 317. 249. 5. *4/WT. 149. 137. 131. 120. 95. 0. *4/*4. 37. 35.

243 views • 12 slides

#4514: Updated results of randomized phase III study of 5-fluorouracil (5-FU) alone versus

#4514: Updated results of randomized phase III study of 5-fluorouracil (5-FU) alone versus combination of irinotecan and cisplatin (CP) versus S-1 alone in advanced gastric cancer (JCOG 9912)

165 views • 1 slides

Background

The Association of Transfer-out Rates From Hospitals Without Revascularization Capabilities and Mortality Risk Among Older NSTEMI Patients.

69 views • 1 slides